Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 17, 2026, 19:56 UTC
  • 7
  • 1 comments

Best Free Virus Protection Tools for Your Digital Security in 2026

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 17, 2026, 19:55 UTC
  • 9
  • 1 comments

Best Shows on Apple TV Plus (2026)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 17, 2026, 19:54 UTC
  • 9
  • 1 comments

Best Games for Xbox Series X (2026)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Jan. 17, 2026, 19:54 UTC
  • 9
  • 1 comments

Best Echo Show Models for Smart Home Integration in 2026

Market reaction Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Jan. 17, 2026, 17:46 UTC
  • 10
  • 1 comments

ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit

Market reaction Comment Full text

uniQure NV (QURE)

  • Business News
  • Jan. 17, 2026, 16:48 UTC
  • 8
  • 1 comments

Notice of QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

Market reaction Comment Full text

4D Molecular Therapeutics (FDMT)

  • Business News
  • Jan. 17, 2026, 13:00 UTC
  • 9
  • 1 comments

4DMT Announces New Employment Inducement Grants

Market reaction Comment Full text

VistaGen Therapeutics Inc. (VTGN)

  • Business News
  • Jan. 17, 2026, 04:43 UTC
  • 12
  • 1 comments

VTGN Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Vistagen Therapeutics, Inc.

Market reaction Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Jan. 17, 2026, 03:15 UTC
  • 9
  • 1 comments

Integer Holdings Corporation Securities Fraud Class Action Result of Overstated Demand and 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Market reaction Comment Full text

Organon & Co. (OGN)

  • Business News
  • Jan. 17, 2026, 02:12 UTC
  • 6
  • 1 comments

Organon & Co. - Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use ofNEXPLANON® (etonogestrel implant) 68 mg Radiopaque

Market reaction Comment Full text
  • Previous
  • 30
  • 31
  • 32
  • 33
  • 34
  • Next

Search

News categories

  • Technical Exchange News(10847)
  • Event(2204)
  • SEC News(187828)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124253)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin